Novanta (NOVT) revenue breakdown
By segment, Automation Enabling Technologies is the largest at 51% of fiscal 2025 revenue; Medical Solutions grew fastest, 16% a year over 9 years.
By region, UNITED STATES is the largest at 53% of fiscal 2025 revenue, growing 14% a year over 9 years.
Revenue by segment
Fiscal years, as Novanta reports them in its 10-K filings; fiscal 2025 total $981M.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Automation Enabling Technologies | — | — | — | — | — | — | $534M | $499M | $491M | $501M | 51% |
| Medical Solutions | $122M | $183M | $233M | $271M | $262M | $262M | $327M | $382M | $459M | $480M | 49% |
| Precision Medicine and Manufacturing | $174M | $232M | $249M | $230M | $200M | $232M | — | — | — | — | — |
| Robotics and Automation | $88M | $106M | $132M | $124M | $129M | $212M | — | — | — | — | — |
Revenue by region
Fiscal years, as Novanta reports them in its 10-K filings; fiscal 2025 total $981M.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $155M | $221M | $242M | $254M | $226M | $271M | $372M | $418M | $487M | $519M | 53% |
| Rest Of Europe | $52M | $81M | $106M | $130M | $127M | $139M | $138M | $137M | $129M | $137M | 14% |
| GERMANY | $56M | $68M | $88M | $82M | $84M | $102M | $134M | $128M | $123M | $115M | 12% |
| Rest of Asia-Pacific | $60M | $85M | $104M | $90M | $74M | $89M | $102M | $105M | $107M | $97M | 10% |
| CHINA | $44M | $56M | $66M | $60M | $71M | $95M | $97M | $73M | $85M | $93M | 10% |
| Other Countries | $18M | $11M | $8M | $11M | $9M | $11M | $18M | $19M | $18M | $19M | 2% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for NOVT.
Open NOVT in InvestinglyQuestions
Where does Novanta make its money?
In fiscal 2025, by segment: Automation Enabling Technologies $501M, Medical Solutions $480M.
From Novanta's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.